Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Avid Bioservices, a Tustin, California-based contract development and manufacturing organization (CDMO) of biopharmaceutical products derived from mammalian cell culture and a wholly owned subsidiary of Peregrine Pharmaceuticals, has provided an...

STA Pharmaceutical, a subsidiary of WuXi AppTec, has signed an investment agreement with the government of Shanghai, Jinshan District, China to build a new research & development (R&D) center. The new facility will support WuXi STA’s...

Cell and Gene Therapy Catapult (CGT Catapult), a center of excellence funded by Innovate UK, the UK government’s innovation agency, to support cell-therapy organizations, has opened a cell- and gene- therapy manufacturing center in Stevenage,...

Dipharma, a Baranzate, Italy-headquartered active pharmaceutical ingredients manufacturer, has agreed to acquire Kalexsyn, a Kalamazoo, Michigan-headquartered contract research organization (CRO) providing chemistry services to the biotechnology...

AMRI, a contract research, development, and manufacturing organization, has renewed a 10-year contract worth up to $39.5 million with the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN). The renewal means AMRI will...

Phoenix Molecular Designs (PhoenixMD), a Vancouver, Canada-headquartered biopharmaceutical company designing cancer therapeutics, has partnered with STA Pharmaceutical, a WuXi AppTec company, to manufacture PMD-026, a first-in-class, specific...

Noramco, a Wilmington, Delaware-headquartered producer of specialty active pharmaceutical ingredients (APIs), and SPI Pharma, a Wilmington, Delaware-headquartered manufacturer and supplier of functional excipient platforms and the development and...

Lonza has partnered with Synpromics, an Edinburgh, UK-based synthetic promoter and gene-control company, to further develop Synpromics’ inducible promoter system and improve manufacturing of biopharmaceuticals. The 18-month project has been made...

Porton Pharma Solutions, a Chongqing, China-headquartered pharmaceutical contract services provider, has partnered with Codexis, a Redwood City, California-headquartered protein engineering and biocatalyst company, to use Codexis’ biocatalyst...